Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Current diagnosis and management of primary chylomicronemia
H Okazaki, T Gotoda, M Ogura, S Ishibashi… - … of Atherosclerosis and …, 2021 - jstage.jst.go.jp
Current Diagnosis and Management of Primary Chylomicronemia Page 1 883 J Atheroscler
Thromb, 2021; 28: 883-904. http://doi.org/10.5551/jat.RV17054 The official journal of the …
Thromb, 2021; 28: 883-904. http://doi.org/10.5551/jat.RV17054 The official journal of the …
Update on the diagnosis, treatment and management of rare genetic lipid disorders
Rare genetic lipid disorders affect the levels of cholesterol and/or triglyceride in the
circulation and, if untreated, can often lead to severe multisystem complications. The field of …
circulation and, if untreated, can often lead to severe multisystem complications. The field of …
Relapsing and progressive complications of severe hypertriglyceridemia: effective long-term treatment with double filtration plasmapheresis
C Grupp, J Beckermann, E Köster, S Zewinger… - Blood purification, 2020 - karger.com
Background: Severe hypertriglyceridemia (HTG) is associated with major complications
such as acute or relapsing pancreatitis (AP) and atherosclerotic cardiovascular disease …
such as acute or relapsing pancreatitis (AP) and atherosclerotic cardiovascular disease …
[HTML][HTML] Pancreatitis Secondary to Dyslipidemia: An Understudied Condition
TH Jacobs, CD Wayne, N Sajankila, S Narayanan - Lipidology, 2024 - mdpi.com
Dyslipidemia (DL), defined by dysregulated levels of lipids in the bloodstream, is an ever-
growing problem in modern society. In addition to those with congenital defects in lipid …
growing problem in modern society. In addition to those with congenital defects in lipid …
[HTML][HTML] Семейная дисбеталипопротеидемия: высокоатерогенное и недостаточно диагностируемое заболевание
АВ Блохина, АИ Ершова, АН Мешков… - Кардиоваскулярная …, 2021 - cyberleninka.ru
Семейная дисбеталипопротеидемия (СДЛП)-наследственное, высокоатерогенное
заболевание, пенетрантность которого зависит от образа жизни пациента и …
заболевание, пенетрантность которого зависит от образа жизни пациента и …
[PDF][PDF] 高脂血症性急性胰腺炎的临床分型及救治方案
周蒙滔， 施可庆， 田新， 李惠萍， 孙洪伟， 刘纳新… - 肝胆胰外科 …, 2019 - gdy.qk.wmu.edu.cn
随着我国社会经济的发展, 人民生活方式和饮食结构的改变, 高脂血症现已成为仅次于胆源性
胰腺炎的第二位急性胰腺炎病因[1]. 高脂血症性胰腺炎具有易复发, 淀粉酶增高不明显 …
胰腺炎的第二位急性胰腺炎病因[1]. 高脂血症性胰腺炎具有易复发, 淀粉酶增高不明显 …
[PDF][PDF] 微创时代中重症与重症急性胰腺炎的外科干预: 时机与方式
勾善淼， 王春友 - 肝胆胰外科杂志, 2019 - gdy.qk.wmu.edu.cn
重症急性胰腺炎(severe acute pancreatitis, SAP) 依然是危重病的代表, 其病死率高达15%,
且以青壮年高发, 高峰发病年龄为50 岁左右. 若获治愈(包括去除病因等), 绝大多数患者可长期 …
且以青壮年高发, 高峰发病年龄为50 岁左右. 若获治愈(包括去除病因等), 绝大多数患者可长期 …
[HTML][HTML] Hypertriglyceridemia Induced Acute Pancreatitis: A Learn from New Cases
An increased risk of morbidity and mortality is associated with acute pancreatitis (AP)
brought on by hypertriglyceridemia (HTG). It is essential to locate the root cause as soon as …
brought on by hypertriglyceridemia (HTG). It is essential to locate the root cause as soon as …
重症急性胰腺炎两次病死高峰的综合救治
周蒙滔， 王春友 - 肝胆胰外科杂志, 2019 - gdy.qk.wmu.edu.cn
重症急性胰腺炎(severe acute pancreatitis, SAP) 依然是危重病的代表, 其病死率高达15%,
且以青壮年高发, 高峰发病年龄为50 岁左右. 若获治愈(包括去除病因等), 绝大多数患者可长期 …
且以青壮年高发, 高峰发病年龄为50 岁左右. 若获治愈(包括去除病因等), 绝大多数患者可长期 …